Assignee
ARIXA PHARMACEUTICALS INC
US·9 granted patents·8 pending applications·22 citations·filing 2018–2024
Top patents by PatentIndex Score
17 records- 0197US10085999B1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Oct 2, 2018·16 cites·30 claims
- 0292US10280161B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted May 7, 2019·5 cites·27 claims
- 0387US2024415847A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0482US10722521B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·1 cites·24 claims
- 0582US2023201218A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0672US2024245705A1Orally administered combinations of amoxicillin and avibactam derivatives for treating mycobacterial infectionsARIXA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0768US10500211B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Dec 10, 2019·0 cites·26 claims
- 0868US2020297733A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0966US2023210863A1Orally administered combinations of beta lactam antibiotics and avibactam derivatives for treating bacterial infectionsARIXA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1063US10815228B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·29 claims
- 1163US10093666B2Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactamsARIXA PHARMACEUTICALS INC·Filed 2018·Granted Oct 9, 2018·0 cites·25 claims
- 1262US2021009580A1Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1359US11008321B2Crystalline form of an avibactam derivativeARIXA PHARMACEUTICALS INC·Filed 2020·Granted May 18, 2021·0 cites·12 claims
- 1459US2021186983A1Orally administered combinations of amoxicillin and avibactam derivatives for treating mycobacterial infectionsARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1552US2021060033A1Orally administered combinations of beta-lactam antibiotics and avibactam derivatives for treating bacterial infectionsARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1651US11565999B2Methods of synthesizing aztreonam derivativesARIXA PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·6 claims
- 1748US11180500B2Derivatives of relebactam and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when ARIXA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →